Central Manchester University Hospitals NHS Foundation Trust
Manchester, M13 9WL, United Kingdom
NCT Number: NCT02196363
Babies that are either very small or very big have increased perinatal morbidity and mortality. Predicting which babies will fall into these groups is traditionally done with risk assessment and third trimester manual palpation, however neither of these techniques are sensitive and a considerable number of affected pregnancies are missed. This results in stillbirth for small babies or birth trauma for larger ones. Serial scanning in the third trimester can improve detection rates but this is expensive and cannot currently be provided to all NHS patients.
A more sensitive test that can be performed earlier in pregnancy would allow identification of at risk pregnancies allowing for increased monitoring. New three dimensional ultrasound techniques that measure volume and volumetric flow have become available that may allow this to happen. This study proposes to trial newer ultrasound techniques on a cohort of pregnant women. The findings from these scans will then be correlated with actual birth weights at the end of pregnancy to determine the ability of these parameters to act as screening tools for babies at the extremes of size.
Looking for future studies?
Notify MeFemale
Observational
Manchester, M13 9WL, United Kingdom
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: up to 34-36 weeks pregnancy gestation
Manchester University NHS Foundation Trust
Other Gov
Acronym: NUPS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02561364
Fetal Development
Memphis, Tennessee, United States
View Trial DetailsNCT04613583
Body Weight, Congenital Abnormalities
Aberdeen, United Kingdom
View Trial DetailsNCT05403632
Fetal Development, Infant Development
Agropoli, SA, Italy
View Trial DetailsNCT06081036
Brain Cortical Thickness, Congenital Abnormalities
Marseille, France
View Trial Details